Active Implants NUsurface Meniscus Study Results

Active Implants NUsurface Implant

Active Implants announced two-year results of the MERCURY study, showing that the company’s NUsurface® Meniscus Implant provides statistically superior pain relief beginning at six months compared to non-surgical therapy.

The NUsurface Implant is the first “artificial meniscus” to be marketed in Europe and is currently under review by FDA. The...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us